Publications

Overview, Hurdles, and Future Work in Adaptive Designs: Perspectives from a National Institutes of HealthFunded Workshop

Coffey CS, Levin B, Clark C, Timmerman C, Wittes J, Gilbert P, and Harris S

Clinical Trials. 2012; 9 (6) 671-680.

PubMed:

Predictors of Lowering Systolic Blood Pressure to Assigned Targets at Twelve Months in the Secondary Prevention of Small Subcortical Strokes (SPS3) Study

Graves JW, White CL, Szychowski JM, Pergola PE, Benavente OR, Coffey CS, Hornung LN, and Hart RG for the SPS3 Investigators

Journal of Hypertension. 2012; 30 1233-1240.

Sample Size Re-Estimation in an Ongoing NIH-Sponsored Clinical Trial: The Secondary Prevention of Small Subcortical Strokes Experience

McClure LA, Szychowski JM, Benavente O, and Coffey CS

Contemporary Clinical Trials. 2012; 33 1088-1093.

The Association of the Metabolic Syndrome with PAI-1 and t-PA Levels

Coffey CS, Asselbergs FW, Hebert PR, Hillege HL, Li Q, Moore JH, and van Gilst WH

Cardiology Research and Practice. 2011; 2011

The Parkinson’s Progression Markers Initiative

The Parkinson’s Progression Markers Initiative Investigators

Progress in Neurobiology. 2011; 95 (4) 629-635.

The Secondary Prevention of Small Subcortical Strokes (SPS3) Study

Benavente OR, White CL, Pearce L, Pergola P, Roldan A, Benavente M, Coffey C, McClure LA, Szychowski JM, Conwit R, Heberling PA, Howard G, Bazan C, Vidal-Pergola G, Talbert R, and Hart RG for the SPS3 Investigators

International Journal of Stroke. 2011; 6 (2) 164-175.

PubMed:

PMC4214141

Very Early Hypothermia Induction in Patients with Severe Brain Injury (National Acute Brain Injury Study: Hypothermia II): A Randomized Trial

Clifton GL, Valadka A, Zygun D, Coffey CS, Drever P, Fourwinds S, Janis LS, Wilde E, Taylor P, Harshman K, Conley A, Puccio A, Levin HS, McCauley SR, Bucholz RD, Smith KR, Schmidt JH, Scott JN, Yonas H, and Okonkwo D

Lancet Neurology. 2011; 10 (2) 131-139.

PubMed:

PMC3628679